By Fineline Cube 
China-based Tibet Aim Pharm, Inc. (SHE: 002826) announced that its controlling shareholder and actual controller, Gao Fan, has entered into a share transfer agreement and supplementary agreement with Beijing Fuhao Enterprise Management Partnership (Limited Partnership) (“Beijing Fuhao”).
Agreement Details
Under the agreement, Beijing Fuhao will acquire 43,855,883 shares of Tibet Aim Pharm from Gao Fan, representing 23.00% of the company’s total shares. Upon completion of this equity change, Beijing Fuhao will become the controlling shareholder of Tibet Aim Pharm, holding 23.00% of the shares. Consequently, the actual controller of Tibet Aim Pharm will change from Gao Fan to Yao Jinbo.
Supplementary Agreement
The supplementary agreement outlines commitments from both parties to collaborate and ensure that multiple subsidiaries of Tibet Aim Pharm fulfill agreed matters. This includes the performance commitment and the recovery of funds.-Fineline Info & Tech